本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2011/1/111 分钟阅读
Trials to Verify and Describe Clinical Benefit of Midodrine Hydrochloride; Establishment of Public Docket
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is announcing the opening of a public docket to provide a forum to facilitate communication regarding the conduct of clinical trials needed to verify and describe the clinical benefit of midodrine hydrochloride (HCl) when used to treat symptomatic orthostatic hypotension.
来源原始语言: Federal Register — Health and Human Services打开原始公告 →